发布日期:2016/12/30 17:36:00
Through the unremitting efforts of the R&D department of the company, Habo Tech has completed the research and development of 5 active molecules with more than 12 steps including lead compounds, phase I clinical targeted drugs and 1.1 new drugs, and successfully obtained the standard sample 10-100g.
Last:Congratulations to Habo on its new package for Grigard's reagent
Next:Habotech will attend CPHI Worldwide 2019!